// App-Quantinova.ai

POS1247 (2021) : CLINICAL FEATURES AND OUTCOMES OF COVID-19 IN PATIENTS WITH IGG4-RELATED DISEASE. A COLLABORATIVE EUROPEAN MULTI-CENTRE STUDY

Researchers

Presenter

  • G. A. Ramirez

Principal Investigators

  • M. Lanzillotta

  • M. Ebbo

  • A. Fernandez-Codina

  • G. Mancuso

  • F. Martnez-Valle

  • O. Orozco-Galvez

  • N. Schleinitz

  • L. Dagna

  • E. Della Torre

Medical Centers

  • IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR),, Milano, Italy

  • Università Vita-Salute San Raffaele, Immunology, Milan, Italy

  • CHU de Marseille - Hôpital de la Timone, Département de Médecine Interne, Marseille, France

  • Aix-Marseille University, Internal Medicine, Marseille, France

  • Windsor Regional Hospital, General Internal Medicine, Windsor, Canada

  • St. Joseph’s Healthcare, Rheumatology, Hamilton, Canada

  • University of Western Ontario, Rheumatology, London, Canada

  • Hospital Clinic i Provincial, Emergency Department, Barcelona, Spain

  • Universitat Autònoma de Barcelona, Autoimmune Diseases Research Lab., Barcelona, Spain

  • Vall d’Hebrón Hospital, Systemic Diseases Unit, Internal Medicine Service, Barcelona, Spain

  • Oxford University Hospital NHS Foundation Trust, Haemophilia & Thrombosis, Oxford, United Kingdom

  • University of Oxford, Translational Gastroenterology, Oxford, United Kingdom

Locations

  • Italy

  • France

  • Canada

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Immunoglobulin G4 related disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved